Images
Participants
Contact
Diario Médico, like many other national and international media, has echoed Patrick Aloy and Miquel Duran’s article, published in the latest issue of Nature Communications. They report on a predictive model that allows the chemical compounds fragments to be related to their positive and negative effects for 20% of human diseases. The results of this study are expected to allow the design of safer drugs, the detection of associations between diseases, and the identification of new uses for drugs that are already on the market.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
